Nurix Therapeutics (NRIX) Other Accumulated Expenses (2019 - 2026)
Nurix Therapeutics (NRIX) reported Other Accumulated Expenses of $1.49 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), down 14.2% from $1.73 million a year earlier but up 13.9% from the prior quarter.
Nurix Therapeutics (NRIX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Other Accumulated Expenses of $2.1 million, down 7.9% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
- By fiscal year, Other Accumulated Expenses came in at $2.28 million in FY2024 (+202.9%), $751,000 in FY2023 (-50.0%), $1.5 million in FY2022 (+128.1%) and $659,000 in FY2021 (-5.9%).
- Five-year quarterly Other Accumulated Expenses spans a low of $551,000 in fiscal Q1 2022 and a high of $2.69 million in fiscal Q1 2025.
- Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with growth averaging 76.0%.
- The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q2 2022 (growth of 272.7%); the low point was fiscal Q4 2023 (a decline of 50.0%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $1.3 million (Q2 2026), $1.93 million (Q1 2026) and $2.1 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 1.49 Mn |
| May 31, 2026 | 1.30 Mn |
| Feb 28, 2026 | 1.93 Mn |
| Nov 30, 2025 | 2.10 Mn |
| Aug 31, 2025 | 1.73 Mn |
| May 31, 2025 | 1.04 Mn |
| Feb 28, 2025 | 2.69 Mn |
| Nov 30, 2024 | 2.28 Mn |
| Aug 31, 2024 | 662,000.00 |
| May 31, 2024 | 1.00 Mn |
| Feb 29, 2024 | 736,000.00 |
| Nov 30, 2023 | 751,000.00 |
| Aug 31, 2023 | 834,000.00 |
| May 31, 2023 | 1.24 Mn |
| Feb 28, 2023 | 1.02 Mn |
| Nov 30, 2022 | 1.50 Mn |
| Aug 31, 2022 | 1.65 Mn |
| May 31, 2022 | 2.24 Mn |
| Feb 28, 2022 | 551,000.00 |
| Nov 30, 2021 | 659,000.00 |
Nurix Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();